Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages
- 15 January 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (2) , 676-678
- https://doi.org/10.1182/blood-2003-05-1739
Abstract
Somatic mosaicism because of in vivo reversion has been recently reported in a small number of patients affected with Wiskott-Aldrich syndrome (WAS). Flow cytometry analysis of WAS protein (WASP) expression has shown that these patients carried revertant cells only among T lymphocytes. Here, we have used high-resolution capillary electrophoresis to analyze genomic DNA from highly purified cells of one of these patients and detected revertant sequences also within the B-cell fraction. The demonstration of revertant cells among both T and B lymphocytes in this patient is consistent with the reversion event having occurred in a common lymphoid progenitor. However, although WASP-expressing T cells showed selective advantage and were readily detectable in the periphery of the mosaic patient, revertant B lymphocytes remained below the detection threshold of flow cytometry. These findings suggest that, contrary to T cells, differentiation and survival of B lymphocytes is minimally dependent on WASP.Keywords
This publication has 12 references indexed in Scilit:
- Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblingsJournal of Clinical Investigation, 2003
- Wiskott-Aldrich syndrome in a femaleBlood, 2002
- Adenosine deaminase deficiency with mosaicism for a “second-site suppressor” of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapyBlood, 2002
- Somatic mosaicism in Wiskott–Aldrich syndrome suggestsin vivoreversion by a DNA slippage mechanismProceedings of the National Academy of Sciences, 2001
- Spontaneous In Vivo Reversion of an Inherited Mutation in the Wiskott-Aldrich SyndromeThe Journal of Immunology, 2001
- Somatic mosaicism in Fanconi anemia: Evidence of genotypic reversion in lymphohematopoietic stem cellsProceedings of the National Academy of Sciences, 2001
- Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient LymphocytesThe Journal of Experimental Medicine, 1999
- Wiskott-Aldrich Syndrome Protein-Deficient Mice Reveal a Role for WASP in T but Not B Cell ActivationImmunity, 1998
- Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiencyNature Genetics, 1996
- Long-term survival after bone marrow transplantation: A 15-year follow-up report of a patient with wiskott-aldrich syndromeThe Journal of Pediatrics, 1984